☰

Craig Anthony Cummings - Publications

Affiliations: 
2000 Stanford University, Palo Alto, CA 
Tree Info Grants Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Chen X, Chang CW, Spoerke JM, Yoh K, Kapoor V, Baudo CD, Aimi J, Yu M, Liang-Chu MMY, Suttman R, Huw LY, Gendreau S, Cummings CA, Lackner MR. Low-Pass Whole-Genome Sequencing of Circulating Cell-Free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30617129 DOI: 10.1158/1078-0432.Ccr-18-1593  0.341
2018 Gandara DR, Paul SM, Kowanetz M, Schleifman E, Zou W, Li Y, Rittmeyer A, Fehrenbacher L, Otto G, Malboeuf C, Lieber DS, Lipson D, Silterra J, Amler L, Riehl T, ... Cummings CA, et al. Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab. Nature Medicine. PMID 30082870 DOI: 10.1038/S41591-018-0134-3  0.316
2018 Lieber DS, White E, Silterra J, Zhong S, Brennan T, Coyne M, Kennedy M, Gandara DR, Kowanetz M, Paul SM, Schleifman E, Li Y, Rittmeyer A, Fehrenbacher L, Amler L, ... ... Cummings C, et al. Abstract A41: Analytic validation and clinical feasibility of a next-generation sequencing assay to assess tumor mutational burden from blood (bTMB) as a biomarker for anti-PD-L1 response in NSCLC Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-A41  0.365
2018 Fabrizio D, Lieber D, Malboeuf C, Silterra J, White E, Coyne M, Brennan T, Ma J, Kennedy M, Schleifman E, Paul S, Li Y, Shames D, Cummings C, Peters E, et al. Abstract 5706: A blood-based next-generation sequencing assay to determine tumor mutational burden (bTMB) is associated with benefit to an anti-PD-L1 inhibitor, atezolizumab Cancer Research. 78: 5706-5706. DOI: 10.1158/1538-7445.Am2018-5706  0.36
2017 Fabrizio D, Malboeuf C, Lieber D, Zhong S, He J, White E, Coyne M, Silterra J, Brennan T, Ma J, Kennedy M, Schleifman E, Paul S, Li Y, Shames D, ... Cummings C, et al. Analytic validation of a next generation sequencing assay to identify tumor mutational burden from blood (bTMB) to support investigation of an anti-PD-L1 agent, atezolizumab, in a first line non-small cell lung cancer trial (BFAST) Annals of Oncology. 28: v27. DOI: 10.1093/Annonc/Mdx363.018  0.327
2016 Cummings CA, Peters E, Lacroix L, Andre F, Lackner MR. The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy. Clinical and Translational Science. PMID 27860319 DOI: 10.1111/Cts.12429  0.328
2014 Rodriguez-Rivera LD, Moreno Switt AI, Degoricija L, Fang R, Cummings CA, Furtado MR, Wiedmann M, den Bakker HC. Genomic characterization of Salmonella Cerro ST367, an emerging Salmonella subtype in cattle in the United States. Bmc Genomics. 15: 427. PMID 24898914 DOI: 10.1186/1471-2164-15-427  0.331
2014 Fong LH, Cha E, Klinger M, Hou Y, Cummings C, Ribas A, Faham M. Abstract 5017: T-cell repertoire turnover induced by anti-CTLA-4 antibody treatment in cancer patients Cancer Research. 74: 5017-5017. DOI: 10.1158/1538-7445.Am2014-5017  0.31
2013 Cha E, Hou Y, Klinger M, Cummings C, Faham M, Ribas A, Fong L. Effect of anti-CTLA-4 antibody treatment on T-cell repertoire evolution in treated cancer patients. Journal of Clinical Oncology. 31: 3020-3020. DOI: 10.1200/Jco.2013.31.15_Suppl.3020  0.306
2012 Moreno Switt AI, den Bakker HC, Cummings CA, Rodriguez-Rivera LD, Govoni G, Raneiri ML, Degoricija L, Brown S, Hoelzer K, Peters JE, Bolchacova E, Furtado MR, Wiedmann M. Identification and characterization of novel Salmonella mobile elements involved in the dissemination of genes linked to virulence and transmission. Plos One. 7: e41247. PMID 22911766 DOI: 10.1371/Journal.Pone.0041247  0.342
2011 den Bakker HC, Moreno Switt AI, Govoni G, Cummings CA, Ranieri ML, Degoricija L, Hoelzer K, Rodriguez-Rivera LD, Brown S, Bolchacova E, Furtado MR, Wiedmann M. Genome sequencing reveals diversification of virulence factor content and possible host adaptation in distinct subpopulations of Salmonella enterica. Bmc Genomics. 12: 425. PMID 21859443 DOI: 10.1186/1471-2164-12-425  0.354
2011 Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, McLaughlin SF, Henkhaus JK, Leopold B, Bielaszewska M, Prager R, et al. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. Plos One. 6: e22751. PMID 21799941 DOI: 10.1371/Journal.Pone.0022751  0.322
2010 den Bakker HC, Cummings CA, Ferreira V, Vatta P, Orsi RH, Degoricija L, Barker M, Petrauskene O, Furtado MR, Wiedmann M. Comparative genomics of the bacterial genus Listeria: Genome evolution is characterized by limited gene acquisition and limited gene loss. Bmc Genomics. 11: 688. PMID 21126366 DOI: 10.1186/1471-2164-11-688  0.383
2010 Cummings CA, Bormann Chung CA, Fang R, Barker M, Brzoska P, Williamson PC, Beaudry J, Matthews M, Schupp J, Wagner DM, Birdsell D, Vogler AJ, Furtado MR, Keim P, Budowle B. Accurate, rapid and high-throughput detection of strain-specific polymorphisms in Bacillus anthracis and Yersinia pestis by next-generation sequencing. Investigative Genetics. 1: 5. PMID 21092340 DOI: 10.1186/2041-2223-1-5  0.347
2009 Cummings CA, Bormann Chung CA, Fang R, Barker M, Brzoska PM, Williamson P, Beaudry JA, Matthews M, Schupp JM, Wagner DM, Furtado MR, Keim P, Budowle B. Whole-genome typing of Bacillus anthracis isolates by next-generation sequencing accurately and rapidly identifies strain-specific diagnostic polymorphisms Forensic Science International: Genetics Supplement Series. 2: 300-301. DOI: 10.1016/J.Fsigss.2009.08.097  0.348
2006 Diavatopoulos DA, Cummings CA, van der Heide HG, van Gent M, Liew S, Relman DA, Mooi FR. Characterization of a highly conserved island in the otherwise divergent Bordetella holmesii and Bordetella pertussis genomes. Journal of Bacteriology. 188: 8385-94. PMID 17041054 DOI: 10.1128/Jb.01081-06  0.355
2006 Brinig MM, Cummings CA, Sanden GN, Stefanelli P, Lawrence A, Relman DA. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. Journal of Bacteriology. 188: 2375-82. PMID 16547023 DOI: 10.1128/Jb.188.7.2375-2382.2006  0.383
2006 Cummings CA, Bootsma HJ, Relman DA, Miller JF. Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. Journal of Bacteriology. 188: 1775-85. PMID 16484188 DOI: 10.1128/Jb.188.5.1775-1785.2006  0.328
2005 Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. Plos Pathogens. 1: e45. PMID 16389302 DOI: 10.1371/Journal.Ppat.0010045  0.319
2004 Jakobsen JS, Jelsbak L, Jelsbak L, Welch RD, Cummings C, Goldman B, Stark E, Slater S, Kaiser D. Sigma54 enhancer binding proteins and Myxococcus xanthus fruiting body development. Journal of Bacteriology. 186: 4361-8. PMID 15205438 DOI: 10.1128/Jb.186.13.4361-4368.2004  0.302
2004 Cummings CA, Brinig MM, Lepp PW, van de Pas S, Relman DA. Bordetella species are distinguished by patterns of substantial gene loss and host adaptation. Journal of Bacteriology. 186: 1484-92. PMID 14973121 DOI: 10.1128/Jb.186.5.1484-1492.2004  0.372
2000 Cummings CA, Relman DA. Using DNA microarrays to study host-microbe interactions. Emerging Infectious Diseases. 6: 513-25. PMID 10998383 DOI: 10.3201/Eid0605.000511  0.355
Show low-probability matches.